5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      NLRX1: Versatile functions of a mitochondrial NLR protein that controls mitophagy

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          NLRX1 is a member of the of the Nod-like receptor (NLR) family, and it represents a unique pattern recognition molecule (PRM) as it localizes to the mitochondrial matrix in resting conditions. Over the past fifteen years, NLRX1 has been proposed to regulate multiple cellular processes, including antiviral immunity, apoptosis, reactive oxygen species (ROS) generation and mitochondrial metabolism. Similarly, in vivo models have shown that NLRX1 was associated with the control of a number of diseases, including multiple sclerosis, colorectal cancer and ischemia-reperfusion injury. This apparent versatility in function hinted that a common and general overarching role for NLRX1 may exist. Recent evidence has suggested that NLRX1 controls mitophagy through the detection of a specific “danger signal”, namely the defective import of proteins into mitochondria, or mitochondrial protein import stress (MPIS). In this review article, we propose that mitophagy regulation may represent the overarching process detected by NLRX1, which could in turn impact on a number of diseases if dysfunctional.

          Highlights

          • NLRX1 controls mitophagy through the detection of a specific “danger signal”: mitochondrial protein import stress (MPIS).

          Related collections

          Most cited references69

          • Record: found
          • Abstract: found
          • Article: not found

          Multiple sclerosis

          The Lancet, 372(9648), 1502-1517
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Parkin and PINK1 mitigate STING-induced inflammation

            Although serum from Parkinson’s disease (PD) patients displays elevated levels of numerous pro-inflammatory cytokines including IL-6, TNFα, IL-1β, and IFNβ1, whether inflammation contributes to or is a consequence of neuronal loss remains unknown 1 . Mutations in Parkin, an E3 ubiquitin ligase, and PINK1, a ubiquitin kinase, cause early-onset PD 2,3 . Working in the same biochemical pathway, PINK1 and Parkin remove damaged mitochondria from cells in culture and in animal models via a selective form of autophagy, called mitophagy 4 . The role of mitophagy in vivo, however, is unclear in part because mice lacking PINK1 or Parkin have no substantial PD-relevant phenotypes 5–7 . As mitochondrial stress can lead to the release of damage-associated molecular patterns (DAMPs) that can activate innate immunity 8–12 , mitophagy may mitigate inflammation. Here we report a strong inflammatory phenotype in both Parkin−/− and PINK1−/− mice following exhaustive exercise (EE) and in Parkin−/−;Mutator mice, which accumulate mitochondrial DNA mutations with age 13,14 . Inflammation resulting from both EE and mtDNA mutation is completely rescued by concurrent loss of STING, a central regulator of the type I Interferon response to cytosolic DNA 15,16 . The loss of dopaminergic (DA) neurons from the substantia nigra pars compacta (SNc) and the motor defect observed in aged Parkin−/−;Mutator mice are also rescued by loss of STING, suggesting that inflammation facilitates this phenotype. Humans with mono- and biallelic Parkin mutations also display elevated cytokines. These results support a role for PINK1- and Parkin-mediated mitophagy in restraining innate immunity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Molecular mechanisms and physiological functions of mitophagy

              Abstract Degradation of mitochondria via a selective form of autophagy, named mitophagy, is a fundamental mechanism conserved from yeast to humans that regulates mitochondrial quality and quantity control. Mitophagy is promoted via specific mitochondrial outer membrane receptors, or ubiquitin molecules conjugated to proteins on the mitochondrial surface leading to the formation of autophagosomes surrounding mitochondria. Mitophagy‐mediated elimination of mitochondria plays an important role in many processes including early embryonic development, cell differentiation, inflammation, and apoptosis. Recent advances in analyzing mitophagy in vivo also reveal high rates of steady‐state mitochondrial turnover in diverse cell types, highlighting the intracellular housekeeping role of mitophagy. Defects in mitophagy are associated with various pathological conditions such as neurodegeneration, heart failure, cancer, and aging, further underscoring the biological relevance. Here, we review our current molecular understanding of mitophagy, and its physiological implications, and discuss how multiple mitophagy pathways coordinately modulate mitochondrial fitness and populations.
                Bookmark

                Author and article information

                Contributors
                Journal
                Biomed J
                Biomed J
                Biomedical Journal
                Chang Gung University
                2319-4170
                2320-2890
                11 August 2023
                February 2024
                11 August 2023
                : 47
                : 1
                : 100635
                Affiliations
                [a ]Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
                [b ]Department of Immunology, University of Toronto, Toronto, Ontario, Canada
                Author notes
                [] Corresponding author. Tel.: +1 416 978 7507. stephen.girardin@ 123456utoronto.ca
                [1]

                Present address: Genentech, 340 Point San Bruno Blvd, South San Francisco, CA 94080, USA.

                Article
                S2319-4170(23)00072-0 100635
                10.1016/j.bj.2023.100635
                10837482
                37574163
                85e9e480-4198-4c9e-8bc5-aea9f2a90dec
                © 2024 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 18 June 2023
                : 20 July 2023
                Categories
                Review Article

                mitochondria,nlrx1,mitophagy,nod-like receptors
                mitochondria, nlrx1, mitophagy, nod-like receptors

                Comments

                Comment on this article